Skip to main content
Darkfield

Ransomware victim disclosure

← All victims

Unknown (Pharmaceutical Company)

Claimed by Rhysida · listed 2 days ago

~5.8 TB
Data size
2,899,290 files records
2d
Age
since listed · listed for ransom

Status timeline

  1. ListedSep 11, 2026

Current state: Listed for ransom

At a glance

Group
Rhysida
Status
Listed for ransom
Sector
Pharmaceutical
Listed on leak site
Sep 11, 2026
Data size
~5.8 TB
Records
2,899,290 files

About the victim

AI dossier — public-source company profile

An unidentified pharmaceutical company subject to government narcotics/BtM (controlled substances) licensing and regulation. The leak post indicates operations spanning accounting, regulatory compliance, and pharmacovigilance functions, with multi-entity corporate structure and international banking relationships.

Industry
Pharmaceutical Manufacturing & Distribution

Attack summary

Severity: critical — Alleged exfiltration of regulated pharmaceutical data including controlled-substance (narcotics/BtM) records, employee PII at scale, government audit documentation, and pharmacovigilance records. Controlled-substance diversion or falsification of regulatory records poses direct public-health and law-enforcement risk. Data volume (5.8 TB) and breadth of sensitive categories meet critical threshold.

Rhysida claims to have exfiltrated approximately 5.8 TB of data (2.9 million files) from a pharmaceutical company. The group alleges capture of accounting records, government audit files, narcotics/controlled-substance licensing documentation, corporate ownership records, executive and employee personal data, and pharmacovigilance correspondence.

critical

Data the group says was taken

AI dossier — extracted from the leak post
  • Accounting records and database backups
  • Government audits (customs, corporate tax, social security, wage tax)
  • Corporate ownership and beneficial-ownership filings
  • Narcotics/controlled-substance records (opioids, cannabis, precursors)
  • Litigation files
  • Executive and employee personal data
  • IT artifacts
  • Pharmacovigilance correspondence

What the group claims

Pharmaceutical company with accounting records, government audit files, corporate ownership documents, narcotics/BtM records, litigation files, and executive personal data.

The leak post

captured from the group's site
Owner�s documents: employee evaluations, salary rates, bonuses, job offers, family documentsCFO�s documents: client credit reports, bankruptcy records, tax documents, father�s medical records (guardianship court case)Corporate financials: owner�s personal tax return, credit application, signed checks with MICR (BNB Bank)Corporate credit cards, drug testsMedical records, employee health insuranceAnd much more
With just 7 days on the clock, seize the opportunity to bid on exclusive, unique, and impressive data. Open your wallets and be ready to buy exclusive data. We sell only to one hand, no reselling, you will be the only owner!
3.502.636 files, total volume ~2.44 TBPatient data (PHI) � name-tagged scans across department shares (surgical pathology, hemodialysis charts, admission records), cancer-center dossiers with PhilHealth IDs, lab quotations incl. cancer-marker tests with birth dates, PhilHealth claims monitoring, neonatal (NICU) dataStaff and professionals � accredited physicians register (cell numbers, PRC licenses, PhilHealth IDs), named payroll workbooks (incl. the affiliated diagnostic center), HR dossiers, staff passport scans, drug-test filesMoney, audit and governance…

Data the group says was taken

  • accounting records
  • database backups
  • government audit files
  • customs records
  • corporate tax records
  • social security records
  • wage tax records
  • corporate ownership documents
  • beneficial ownership filings
  • related-party payments
  • narcotics records
  • opioid records
  • cannabis records
  • precursor records
  • litigation files
  • executive personal data
  • employee personal data
  • IT artifacts
  • pharmacovigilance correspondence

Screenshot of the leak post

Leak screenshot for Unknown (Pharmaceutical Company)

Sources

Source

Indexed 2 days ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About Rhysida

Rhysida is a ransomware group that emerged in June 2023, operating with primarily financial motivations through targeted attacks against critical infrastructure and public sector organizations. The group's origin and potential state affiliations remain unclear, though they operate independently rather than as a traditional Ransomware-as-a-Service model, with limited public documentation regarding connections to other cybercriminal organizations. Rhysida employs double extortion tactics, typically gaining initial access through compromised VPN credentials and exploiting vulnerable public-facing applications before deploying their ransomware payload and exfiltrating sensitive data prior to encryption. The group has demonstrated a particular focus on healthcare and educational institutions, with notable attacks documented by CISA and FBI advisories highlighting their targeting of hospitals and school districts across multiple countries, resulting in significant operational disruptions to critical services. As of late 2024, Rhysida remains an active threat with continued operations targeting organizations primarily in the United States, Canada, and other Western nations, maintaining their focus on high-value sectors where operational disruption can maximize ransom payment likelihood. The group has been linked to 324 public disclosures across our corpus. First observed on a leak site on June 5, 2023; most recent post September 13, 2026. The operation is currently active.

Timeline of this disclosure

  • September 11, 2026Unknown (Pharmaceutical Company) listed by Rhysida on the group's public leak site
Data size
~5.8 TB
Records
2,899,290 files

Other recent disclosures by Rhysida

Rhysida has been linked to 324 public victims on Darkfield. A sample of the most recent:

See the full Rhysida dossier →

Sector and geography

This disclosure adds to ransomware activity in the Pharmaceutical sector, which has 33 disclosures indexed across all operators we track.

If your organisation is affected

A listing by Rhysida means Unknown (Pharmaceutical Company) appeared on a ransomware extortion site and is being pressured to pay before any publication. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

  • Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
  • Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
  • Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
  • Monitor for the data appearing on Rhysida's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.